Citation

89 FR 18641

Multiple canonical documents share this first-page citation.

Determination of Regulatory Review Period for Purposes of Patent Extension; PYRUKYND Thursday, March 14, 2024 89 FR 18641
Hoffmann-La Roche, Inc., et al.; Withdrawal of Approval of Two New Drug Applications; Correction Thursday, March 14, 2024 89 FR 18641
Notice of Closed Meeting Thursday, March 14, 2024 89 FR 18641